Chemoressa is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Non-Small Cell Lung Cancer. Other than this, Chemoressa has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Chemoressa depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Chemoressa also has some side effects, the most common being Weakness, Dry Skin, Dark colored (brown) urine. Apart from the aforementioned side effects, Chemoressa can also lead to other problems, which have been listed below. Normally, these side effects of Chemoressa are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Chemoressa is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Chemoressa has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Chemoressa related warnings section.
Chemoressa is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Gastritis are examples of such conditions. Other contraindications of Chemoressa have been discussed in the sections ahead.
Drug reaction of Chemoressa with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Chemoressa is considered not safe while driving, and is not addictive.
Chemoressa is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Chemoressa safe for pregnant women?
Pregnant women may get severe side effects after taking Chemoressa. If you are pregnant, do not take Chemoressa without a doctor's advice.
Is the use of Chemoressa safe during breastfeeding?
Chemoressa may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Chemoressa on the Kidneys?
Chemoressa has very mild side effects on the kidneys.
What is the effect of Chemoressa on the Liver?
Chemoressa is rarely harmful for the liver.
What is the effect of Chemoressa on the Heart?
Chemoressa is not harmful for the heart.
Chemoressa should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Chemoressa unless your doctor advises you to do so -
Is this Chemoressa habit forming or addictive?
No, you will not get addicted to Chemoressa.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Chemoressa. So it is best to avoid driving.
Is it safe?
Yes, Chemoressa is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Chemoressa in mental disorders is not effective.
Interaction between Food and Chemoressa
Taking Chemoressa with food is safe.
Interaction between Alcohol and Chemoressa
Due to lack of research, there is no information about the side effects of taking Chemoressa with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Iressa (gefitinib tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 610-612